IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
QIP Nominees Pty Ltd v Delinia, Inc. [2021] APO 24
Patent Application: 2015292889
Title:Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Patent Applicant: Delinia, Inc.
Opponent:QIP Nominees Pty Ltd
Delegate:Xavier Gisz
Decision Date: 22 June 2021
Hearing Date: 18 June 2021, in Video Conference
Catchwords: PATENTS - regulation 5.9(2) – extension of time to file evidence in answer – whether there are exceptional circumstances that warrant an extension – extension granted
Representation:
Counsel for the Applicant: Patrick Flynn SC of Eleven Wentworth
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2015292889
Title:Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases
Patent Applicant: Delinia, Inc.
Date of Decision: 22 June 2021
DECISION
I allow the extension of time under regulation 5.9(2)(b) for the Applicant to file the Evidence in Answer up to 4 May 2021. The consideration of the stay of the opposition is currently taking place and will be decided separately to this decision.
REASONS FOR DECISION
Background
Patent application 2015292889 (the Application) in the name of Delinia, Inc. (the Applicant) is the national phase entry of PCT/US2015/041177 (with publication number WO 2016/014428) which was filed on 20 July 2015. Examination was requested on 15 June 2018. The Application was accepted on 10 February 2020 and acceptance was advertised on 27 February 2020.
A Notice of Opposition to the grant of the patent was filed on 27 May 2020 by QIP Nominees Pty Ltd (the Opponent). A Statement of Grounds and Particulars was filed on 27 August 2020. Evidence in Support was filed on 27 November 2020, and acknowledged on 4 December 2020. Evidence in Answer was, therefore, due on 4 March 2021.
On 19 February 2021 the Applicant filed a request for an extension of time to file Evidence in Answer. This request was accompanied by declarations of Bernard Nutt, Jay Wilusz, and Basil Krikelis. On 21 February 2021 the Applicant filed a declaration by Lisa Taliadoros.
On 24 February 2021 the Delegate requested more information about the circumstances that led up to the request for an extension of time to file Evidence in Answer.
On 26 February 2021 the Delegate wrote to the Applicant asking whether some of the information in the first Krikelis declaration needed to be kept confidential as was suggested in the declaration itself.
On 4 March 2021 the Applicant filed Evidence in Answer comprising a declaration by Mark Rubenstein with annexures MR-1 to MR-6. The cover letter of the Evidence in Answer stated:
“These documents complete the Applicant’s Evidence in Answer”.
On 5 March 2021 the Delegate sent a letter to the Applicant stating:
“We acknowledge a declaration by Mark Rubinstein with Annexures MR-1 to MR-6 on 4 March 2021 which completes the Evidence in Answer.
Evidence in Reply is now due to be filed by the opponent on or before 5 May 2021.”
On 10 March 2021 the Applicant filed submissions on the extension of time and a second declaration…
Keep reading for free
Create a free CaseChat account to read QIP Nominees Pty Ltd v Delinia, Inc and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] APO 24
- Decision Date
CaseChat Overview and Summary
The legal issues before the Delegate were whether there were exceptional circumstances under regulation 5.9(2)(b) that warranted an extension of time for Delinia to file its Evidence in Answer, and if so, what period of extension would be appropriate. Delinia argued that the blocking of emails by its US patent attorney was a circumstance beyond its control, and that it was unreasonable to expect it to prepare its Evidence in Answer within one month of becoming aware of the opposition. The Delegate had to weigh Delinia's arguments against the strict deadlines in opposition matters, and decide whether an extension was warranted.
The Delegate allowed the extension of time under regulation 5.9(2)(b), finding that the blocking of emails by Delinia's US patent attorney was a circumstance beyond its control. The Delegate accepted that Delinia was unaware of the opposition until two months before the deadline for filing Evidence in Answer, and that it was unreasonable to expect it to prepare its Evidence in Answer within one month. The Delegate also found that a two-month extension was reasonable, given the circumstances. However, the Delegate deferred consideration of a further extension of time until a decision was made on Delinia's request to stay the opposition.
The Delegate granted Delinia a two-month extension of time to file its Evidence in Answer, up until 4 May 2021. The Delegate noted that the stay of the opposition would be decided separately to this decision.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi